James Frates Joins Amylyx Prescription drugs as Chief Economical Officer | Business enterprise & Finance

CAMBRIDGE, Mass.–(Small business WIRE)–Jan 14, 2021– Amylyx Pharmaceuticals, Inc., a pharmaceutical organization targeted on acquiring new treatment options for amyotrophic lateral sclerosis (ALS), Alzheimer’s Illness